PYPL
62
2
A
41
-3
GD
39
-2
LH
36
-3
NDAQ
56
4
IR
58
-2
DTE
47
-2
URI
45
-4
PFG
33
-3
AMP
54
2
VZ
37
-2
EXC
51
-2
HCP
52
9
RIG
54
7
QCOM
55
4
IP
54
-2
XYL
41
-13
ISRG
71
3
HBAN
56
2
ADSK
67
2
PYPL
62
2
A
41
-3
GD
39
-2
LH
36
-3
NDAQ
56
4
IR
58
-2
DTE
47
-2
URI
45
-4
PFG
33
-3
AMP
54
2
VZ
37
-2
EXC
51
-2
HCP
52
9
RIG
54
7
QCOM
55
4
IP
54
-2
XYL
41
-13
ISRG
71
3
HBAN
56
2
ADSK
67
2
Financhill
Back

Y-mAbs Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
29

YMAB
Y-mAbs Therapeutics

Last Price:
10.01
Seasonality Move:
12.09%
Sell
16

NBY
NovaBay Pharmaceuticals

Last Price:
0.54
Seasonality Move:
-8.54%
Sell
29
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $10.01. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $10.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 32.47 Sell
Chaikin Money Flow: -71841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.89 - 13.51) Sell
Bollinger Bands (100): (11.39 - 14.57) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 32.51 Sell
Chaikin Money Flow: -111892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 0.97) Sell

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.52 Sell
20-day SMA: 10.89 Sell
50-day SMA: 13.07 Sell
200-day SMA: 13.45 Sell
8-day EMA: 10.47 Sell
20-day EMA: 11.22 Sell
50-day EMA: 12.31 Sell
200-day EMA: 12.4 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2.04 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.68 Sell
200-day EMA: 5 Sell

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):